Cite
Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
MLA
Vaishali P. Waman, et al. “Predicting Human and Viral Protein Variants Affecting COVID-19 Susceptibility and Repurposing Therapeutics.” Scientific Reports, vol. 14, no. 1, June 2024, pp. 1–19. EBSCOhost, https://doi.org/10.1038/s41598-024-61541-1.
APA
Vaishali P. Waman, Paul Ashford, Su Datt Lam, Neeladri Sen, Mahnaz Abbasian, Laurel Woodridge, Yonathan Goldtzvik, Nicola Bordin, Jiaxin Wu, Ian Sillitoe, & Christine A. Orengo. (2024). Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics. Scientific Reports, 14(1), 1–19. https://doi.org/10.1038/s41598-024-61541-1
Chicago
Vaishali P. Waman, Paul Ashford, Su Datt Lam, Neeladri Sen, Mahnaz Abbasian, Laurel Woodridge, Yonathan Goldtzvik, et al. 2024. “Predicting Human and Viral Protein Variants Affecting COVID-19 Susceptibility and Repurposing Therapeutics.” Scientific Reports 14 (1): 1–19. doi:10.1038/s41598-024-61541-1.